Where does Nisshin Pharma Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nisshin Pharma Inc. ranks #36,708 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nisshin Pharma Inc. hold?

Nisshin Pharma Inc. holds 7 US utility patents granted between 2016 and 2025, spanning 10 technology areas.

What is Nisshin Pharma Inc.'s Innovation Score?

Nisshin Pharma Inc. has an Innovation Score of 29.3 out of 100 (30th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Nisshin Pharma Inc.'s patent grant rate increasing or decreasing?

Nisshin Pharma Inc.'s recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Nisshin Pharma Inc.'s patents?

Nisshin Pharma Inc.'s patents average 14.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nisshin Pharma Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nisshin Pharma Inc.

Q: What technology areas does Nisshin Pharma Inc. focus on?

Nisshin Pharma Inc.'s top technology area is C11B (Producing, e.g. BY Pressing RAW Materials OR BY Extraction From Waste Materials, Refining OR Preserving Fats, Fatty Substances, e.g. Lanolin, Fatty Oils OR WAXES; Essential OILS; Perfumes) with 5 patents, ranking #46 of 233 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C11B (Producing, e.g. BY Pressing RAW Materials OR BY Extraction From Waste Materials, Refining OR Preserving Fats, Fatty Substances, e.g. Lanolin, Fatty Oils OR WAXES; Essential OILS; Perfumes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nisshin ranks #36,708 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 10 technology areas.

#36,708
of 49,997 US assignees by volume: 30th percentile
by Innovation Score (29.3/100): 14.6
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R36708 · Foreign Corporation #36,708 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #36,708/49,997
PHOTO-FINISH Ningbo Xuanhua…
CPC-FOCUS C11B · 10 areas
INNOV-THIN 29.3/100
CLAIMS-RICH 14.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ningbo Xuanhua Electric Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nisshin’s 29.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (25%) Velocity 2.2 pts (8%) Breadth 11.2 pts (38%) Claim depth 8.7 pts (30%)

Qualcomm Incorporated · highest

85
Nisshin Pharma · this assignee

29
3D Lighting… · lowest

7

What this shows Nisshin's Innovation Score is 29.3/100 (30th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nisshin?

Each dot is one of Nisshin’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nisshin’s own 14.6 claims/patent is ABOVE the 9.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nisshin vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nisshin's grants concentrate

Nisshin Pharma Inc. is a focused PatentsView assignee: 10 CPC subclasses with 71.4% of grants classified under C11B (Producing, e.g. BY Pressing RAW Materials OR BY Extraction From Waste Materials, Refining OR Preserving Fats, Fatty Substances, e.g. Lanolin, Fatty Oils OR WAXES; Essential OILS; Perfumes). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2021. By volume, Nisshin sits between Ningbo Xuanhua Electric Co., Ltd. and NLB, Corp..

Nisshin's three-year grant acceleration

Nisshin Pharma Inc. shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ningbo Xuanhua El…

7
Nippon OIL

7
Niramai Health An…

7
Nishina Industrial

7
Nitricgen

7
Nitto Belgium

7
Nitto Kasei

7
NLB

7
Nisshin Pharma ◀

7

What this shows Nisshin holds 7 patents at rank #36,633, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nisshin

By rank, the assignees closest to #36,633 in granted patent volume.

Leaders in C11B (Producing)

Other assignees with the most granted patents in Nisshin's primary technology class.

Nisshin's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 30th percentile higher than 30% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Nisshin Pharma Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	28.6%
2020	2	28.6%
2021	1	14.3%
2023	1	14.3%
2025partial year	1	14.3%

Which technologies does Nisshin Pharma Inc. patent most?

C11B - Producing, e.g. BY Pressing RAW Materials OR BY Extraction From Waste Materials, Refining OR Preserving Fats, Fatty Substances, e.g. Lanolin, Fatty Oils OR WAXES; Essential OILS; Perfumes 5

C11C - Fatty Acids From Fats, Oils OR WAXES; CANDLES; Fats, Oils OR Fatty Acids BY Chemical Modification OF Fats, Oils, OR Fatty Acids Obtained Therefrom 4

C07C - Acyclic OR Carbocyclic Compounds 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

C12Y - Enzymes 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nisshin Pharma Inc.'s patent record in context - here's where to go next.

Nisshin Pharma Inc.'s lead technology class is C11B (Producing, e.g. BY Pressing RAW Materials OR BY Extraction From Waste Materials, Refining OR Preserving Fats, Fatty Substances, e.g. Lanolin, Fatty Oils OR WAXES; Essential OILS; Perfumes), 71.4% of its portfolio - see every assignee active in that class. Explore C11B
Ranked #36,708 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nisshin Pharma Inc. against Ningbo Xuanhua Electric Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.